contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


getinge-announces-its-year-end-report-2022-on-february-1-at-0800-cet-followed-by-a-conference-call-at-1000-cet

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Getinge är ett globalt medicintekniskt bolag som specialiserar sig på att tillhandahålla utrustning och IT-system till hälso- och sjukvården samt life science-industrin. Bolaget erbjuder bland annat lösningar för operationssalar, intensivvårdsavdelningar, steriliseringscentraler och läkemedelsutveckling. Bolaget grundades 1904 och har sitt huvudkontor i Göteborg.

Getinge

Getinge will issue its Year-End Report 2022 on February 1, 2023, at 08:00 CET, followed by a conference call at 10:00 CET, hosted by Mattias Perjos, President & CEO, and Lars Sandström, CFO....

<div class="abstract">Getinge will issue its Year-End Report 2022 on February 1, 2023, at 08:00 CET, followed by a conference call at 10:00 CET, hosted by Mattias Perjos, President &amp; CEO, and&nbsp;Lars Sandström, CFO.</div>Fund managers, analysts and media are invited to participate in the conference call. Please see dial in details below to join the conference:SE: +46-8-5051-6386 UK: +44-20-319-84884 US: +1-412-317-6300 Pin code: 6209909#During the conference call a presentation will be held. To access the presentation through webcast, please use this link: <a href="https://ir.financialhearings.com/getinge-q4-2022">https://ir.financialhearings.com/getinge-q4-2022&nbsp;</a>Alternatively, use the following link to download the presentation: <a href="https://www.getinge.com/int/about-us/investors/reports-presentations/">https://www.getinge.com/int/about-us/investors/reports-presentations/</a>Agenda 09:45 &nbsp;&nbsp; Dial in to the conference 10:00 &nbsp;&nbsp; Presentation 10:30 &nbsp;&nbsp; Q&amp;A 11:00 &nbsp;&nbsp; End of conferenceRecording available for 3 years A recorded version can be accessed for 3 years via <a href="https://ir.financialhearings.com/getinge-q4-2022">https://ir.financialhearings.com/getinge-q4-2022&nbsp;</a>Contact information Lars Mattsson, Head of Investor Relations Phone: &nbsp;+46(0)10 335 0043 E-mail: &nbsp;lars.mattsson@getinge.com About Getinge With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in 135 countries.

Getinge announces its Year-End Report 2022 on February 1 at 08:00 CET followed by a conference call at 10:00 CET